These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 9123167)
21. Injury of peritubular capillaries correlates with graft function in chronic renal allograft nephropathy. Ishii Y; Shimizu A; Sawada T; Tojimbara T; Nakajima I; Fuchinoue S; Teraoka S; Yamaguchi Y; Yamanaka N Transplant Proc; 2001; 33(1-2):1213-4. PubMed ID: 11267264 [No Abstract] [Full Text] [Related]
22. Morphological characteristics of renal allografts showing renal dysfunction under FK 506 therapy: is graft biopsy available to reveal the morphological findings corresponding with FK 506 nephropathy? Japanese FK 506 Study Group. Transplant Proc; 1993 Feb; 25(1 Pt 1):624-7. PubMed ID: 7679824 [No Abstract] [Full Text] [Related]
23. Allograft instability with frequent acute rejections and early chronic transplant glomerulopathy related to suboptimal doses of cyclosporine A. Savin M; Petronic V; Djukanovic L; Dujic A; Stojkovic D; Sindjic M Transplant Proc; 1997 Nov; 29(7):2977-9. PubMed ID: 9365636 [No Abstract] [Full Text] [Related]
24. Expression and distribution of thrombomodulin on endothelial cells in kidney transplants with acute vascular rejection. Yamaguchi Y; Onitsuka S; Horita S; Tanabe K; Yagisawa T; Kawaguchi H; Ito K; Toma S; Ota K Transplant Proc; 1997; 29(1-2):164-6. PubMed ID: 9122945 [No Abstract] [Full Text] [Related]
25. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506. Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495 [No Abstract] [Full Text] [Related]
26. An experimental model of chronic kidney allograft rejection under triple-drug treatment in the rat. Soots A; Lautenschlager I; Krogerus L; Saarinen O; Ahonen J Transplant Proc; 1997 Nov; 29(7):3152. PubMed ID: 9365704 [No Abstract] [Full Text] [Related]
27. Clinical validity of Banff grading of chronic rejection in renal transplantation. Oh CK; Jeong HJ; Kim YS; Kim MS; Choi KH; Lee HY; Han DS; Park K Transplant Proc; 1996 Jun; 28(3):1441-2. PubMed ID: 8658731 [No Abstract] [Full Text] [Related]
28. Effect of acute rejection on expression of fibrosis associated genes in renal transplant recipients. White SA; Bicknell GR; Jain S; Williams ST; Doughman T; Furness P; Nicholson ML Transplant Proc; 2000 Feb; 32(1):19-20. PubMed ID: 10700949 [No Abstract] [Full Text] [Related]
29. Long-term effects of chronic cyclosporine nephropathy on outcome of renal allografts. Takeda A; Morozumi K; Haba T; Katayama A; Tominaga Y; Uchida K Transplant Proc; 2001; 33(7-8):3379-80. PubMed ID: 11750445 [No Abstract] [Full Text] [Related]
30. Reviewing the pathogenesis of antibody-mediated rejection and renal graft pathology after kidney transplantation. Morozumi K; Takeda A; Otsuka Y; Horike K; Gotoh N; Narumi S; Watarai Y; Kobayashi T Nephrology (Carlton); 2016 Jul; 21 Suppl 1():4-8. PubMed ID: 26971899 [TBL] [Abstract][Full Text] [Related]
31. Reversal of accelerated renal allograft rejection with FK 506. Woodle ES; Newell KA; Haas M; Bartosh S; Josephson MA; Millis JM; Bruce DS; Piper JB; Aronson AJ; Thistlethwaite JR Clin Transplant; 1997 Aug; 11(4):251-4. PubMed ID: 9267710 [TBL] [Abstract][Full Text] [Related]
32. Morphological criteria of chronic rejection: differential diagnosis, including cyclosporine nephropathy. Mihatsch MJ; Ryffel B; Gudat F Transplant Proc; 1993 Apr; 25(2):2031-7. PubMed ID: 8470264 [No Abstract] [Full Text] [Related]
33. Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach. Turner CD; Bruce DS; Cronin DC; Loss GE; Grewal H; Siegel C; Millis JM; Newell KA; Davis B; Todo T; Thistlethwaite JR; Woodle ES Transplant Proc; 1998 Jun; 30(4):1234-5. PubMed ID: 9636501 [No Abstract] [Full Text] [Related]
34. Role of peritubular capillaries and vascular endothelial growth factor in chronic allograft nephropathy. Modelli de Andrade LG; Viero RM; Carvalho MF Transplant Proc; 2009 Nov; 41(9):3720-5. PubMed ID: 19917374 [TBL] [Abstract][Full Text] [Related]
35. Tacrolimus rescue therapy in late rejection after renal transplantation: outcome after 18 months. Budde K; Fritsche L; Smettan S; Schönberger B; Loening SA; Mai I; Bauer S; Waiser J; Neumayer HH Transplant Proc; 1998 Jun; 30(4):1238-9. PubMed ID: 9636503 [No Abstract] [Full Text] [Related]
36. Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis. Shimizu A; Yamada K; Sachs DH; Colvin RB Kidney Int; 2002 May; 61(5):1867-79. PubMed ID: 11967039 [TBL] [Abstract][Full Text] [Related]
37. Preliminary analysis of a randomized trial comparing microemulsion cyclosporine and tacrolimus for recipients of renal transplants from non-heart-beating donors. Williams ST; Knight AL; White SA; Doughman TM; Nicholson ML Transplant Proc; 2000 Feb; 32(1):196. PubMed ID: 10701022 [No Abstract] [Full Text] [Related]
39. The Banff classification of renal allograft pathology: where do we go from here? Racusen L; Rayner D; Trpkov K; Olsen S; Solez K Transplant Proc; 1996 Feb; 28(1):486-8. PubMed ID: 8644322 [No Abstract] [Full Text] [Related]
40. Improvement of lesion quantitation for the Banff schema for renal allograft rejection. Racusen LC Transplant Proc; 1996 Feb; 28(1):489-90. PubMed ID: 8644323 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]